Eric Bateman

16.4k total citations
80 papers, 4.5k citations indexed

About

Eric Bateman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Eric Bateman has authored 80 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 36 papers in Physiology and 6 papers in Epidemiology. Recurrent topics in Eric Bateman's work include Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Asthma and respiratory diseases (33 papers) and Respiratory Support and Mechanisms (22 papers). Eric Bateman is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Asthma and respiratory diseases (33 papers) and Respiratory Support and Mechanisms (22 papers). Eric Bateman collaborates with scholars based in South Africa, United Kingdom and United States. Eric Bateman's co-authors include Donald Banerji, Dirk Bredenbröker, Klaus F. Rabe, Lesley Towse, Peter Burney, Michael Studnicka, Stephan Witte, Esther García Gil, Denis O’Donnell and Gary T. Ferguson and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Radiology.

In The Last Decade

Eric Bateman

79 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Bateman South Africa	32	3.6k	2.5k	465	390	249	80	4.5k
Theodore J. Witek United States	27	2.8k 0.8×	2.1k 0.9×	378 0.8×	125 0.3×	164 0.7×	69	3.9k
J. Mark FitzGerald Canada	27	1.7k 0.5×	1.3k 0.5×	507 1.1×	415 1.1×	105 0.4×	58	2.8k
Andrew McIvor Canada	29	1.9k 0.5×	1.8k 0.7×	385 0.8×	151 0.4×	150 0.6×	106	3.0k
Jadwiga A. Wedzicha United Kingdom	26	3.3k 0.9×	1.6k 0.6×	438 0.9×	75 0.2×	317 1.3×	61	4.0k
Terence Seemungal Trinidad and Tobago	20	4.7k 1.3×	2.2k 0.9×	1.1k 2.4×	107 0.3×	188 0.8×	69	5.7k
Ki‐Suck Jung South Korea	25	1.2k 0.3×	687 0.3×	447 1.0×	235 0.6×	187 0.8×	165	2.5k
J. Mark FitzGerald Canada	26	3.2k 0.9×	4.1k 1.7×	277 0.6×	251 0.6×	256 1.0×	85	5.4k
Sonia Buist United States	24	6.0k 1.6×	2.8k 1.1×	655 1.4×	126 0.3×	404 1.6×	44	7.4k
Dennis E. Niewoehner United States	40	4.8k 1.3×	2.3k 0.9×	552 1.2×	64 0.2×	444 1.8×	96	6.1k
Miguel Divo United States	27	2.8k 0.8×	1.1k 0.4×	586 1.3×	62 0.2×	202 0.8×	79	3.8k

Countries citing papers authored by Eric Bateman

Since Specialization

Citations

This map shows the geographic impact of Eric Bateman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Bateman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Bateman more than expected).

Fields of papers citing papers by Eric Bateman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Bateman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Bateman. The network helps show where Eric Bateman may publish in the future.

Co-authorship network of co-authors of Eric Bateman

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Bateman. A scholar is included among the top collaborators of Eric Bateman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Bateman. Eric Bateman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allwood, Brian, Elizna Maasdorp, Grace J. Kim, et al.. (2020). <p>Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis</p>. International Journal of COPD. Volume 15. 1039–1047. 29 indexed citations

Amaral, André F.S., Jaymini Patel, Bernet Kato, et al.. (2017). Airflow Obstruction and Use of Solid Fuels for Cooking or Heating. BOLD (Burden of Obstructive Lung Disease) Results. American Journal of Respiratory and Critical Care Medicine. 197(5). 595–610. 46 indexed citations

Chapman, Kenneth R., Eric Bateman, Nicola Gallagher, Huilin Hu, & Donald Banerji. (2014). Once-Daily QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Disease Severity and Prior Medications: The SHINE Study. CHEST Journal. 145(3). 401A–401A. 2 indexed citations

Singh, Dave, Paul Jones, Eric Bateman, et al.. (2014). Evaluation of the Efficacy and Safety of Two Doses of Aclidinium and Formoterol in Fixed-Dose Combination in Patients With COPD: The ACLIFORM Study. CHEST Journal. 145(3). 375A–375A. 7 indexed citations

Allwood, Brian, Luís Taborda‐Barata, Greg Calligaro, et al.. (2014). The burden of obstructive lung disease (BOLD) methodology overestimates the prevalence of COPD: A 5-year follow-up study. European Respiratory Journal. 44(Suppl 58). P1084–P1084. 1 indexed citations

Chapman, Kenneth R., Eric Bateman, Petter Olsson, et al.. (2014). Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study. European Respiratory Journal. 44(Suppl 58). P918–P918. 1 indexed citations

Buhl, Roland, Eric Derom, Gary T. Ferguson, et al.. (2014). Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies. European Respiratory Journal. 44(Suppl 58). 1895–1895. 2 indexed citations

Chapman, Kenneth R., et al.. (2014). QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE Studies. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 2(1). 48–60. 7 indexed citations

Hohlfeld, Jens M., et al.. (2014). Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter‐ECG data from four randomised clinical trials. International Journal of Clinical Practice. 69(1). 72–80. 14 indexed citations

10.

Kerstjens, Huib A.M., Eugene R. Bleecker, Eli O. Meltzer, et al.. (2013). Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety. European Respiratory Journal. 42(Suppl 57). 4629–4629. 4 indexed citations

11.

Kerstjens, Huib A.M., Eugene R. Bleecker, Eli O. Meltzer, et al.. (2013). Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate. European Respiratory Journal. 42(Suppl 57). P4130–P4130. 5 indexed citations

12.

Singh, David, Eric Bateman, Paul Jones, et al.. (2011). The ATTAIN study: Bronchodilatory effect of aclidinium bromide in chronic obstructive pulmonary disease (COPD). European Respiratory Journal. 38(Suppl 55). p875–p875. 1 indexed citations

13.

Price, David A., David Halpin, Robert J. Winter, et al.. (2011). Missed opportunities to diagnose COPD. European Respiratory Journal. 38(Suppl 55). 182–182. 1 indexed citations

14.

Agustí, Àlvar, Paul Jones, Eric Bateman, et al.. (2011). Improvement in symptoms and rescue medication use with aclidinium bromide in patients with chronic obstructive pulmonary disease: Results from ATTAIN. European Respiratory Journal. 38(Suppl 55). p874–p874. 5 indexed citations

15.

Dawson, Rod, David Edwards, Eric Bateman, et al.. (2010). Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV.. PubMed. 14(1). 52–8. 72 indexed citations

16.

Hanania, Nicola A., Eric Bateman, Peter M.A. Calverley, et al.. (2010). Benefits of Roflumilast Treatment on Exacerbation Outcomes in Patients With COPD: Pooled Results From Two Pivotal 12-Month Studies. CHEST Journal. 138(4). 801A–801A. 1 indexed citations

17.

Bateman, Eric, Donald P. Tashkin, Nikolaos M. Siafakas, et al.. (2010). A one-year trial of tiotropium Respimat® plus usual therapy in COPD patients. Respiratory Medicine. 104(10). 1460–1472. 89 indexed citations

18.

ZuWallack, Richard, María Cristina De Salvo, Eric Bateman, et al.. (2010). Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat® inhaler versus MDI. Respiratory Medicine. 104(8). 1179–1188. 13 indexed citations

19.

Zyl-Smit, Richard N. van, Madhukar Pai, Wing Wai Yew, et al.. (2009). Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. European Respiratory Journal. 35(1). 27–33. 200 indexed citations

20.

Voshaar, Thomas, et al.. (2007). A randomized study of tiotropium Respimat® Soft MistTM Inhaler vs. ipratropium pMDI in COPD. Respiratory Medicine. 102(1). 32–41. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact